News CRISPR Therapeutics plans Nasdaq launch CRISPR Therapeutics, the Swiss genome-editing company, has filed for a $90 million initial public offering.
News Biogen’s haemophilia spin-out Bioverativ to launch early 201... Coming antibody drugs and gene therapy could transform treatment
News New haemophilia drug Elocta approved in Europe Elocta, a new drug co-marketed by Sobi and Biogen, has been approved in the European Union.
News Gilead, MSD share data on once-weekly oral HIV treatment Gilead/MSD's once-weekly oral medicine for HIV has been shown to achieve high rates of viral suppression in phase 3, setting up regulatory filings.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
